List of insiders holdings for Celularity Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | STARR INTERNATIONAL CO INC Starr International Investments Ltd. 10% Owner | 2023-02-13 17:13:31 | 15,281,389 0 | 15,281,389 | Form 13G |
| 2 | GX Sponsor LLC 10% Owner | 2021-07-20 21:34:58 | 14,187,500 0 | 14,187,500 | Form 4 |
| 3 | Lim Kok Thay Dragasac Ltd Genting Berhad 10% Owner | 2025-07-28 21:44:21 | 14,138,161 0 | 14,138,161 | Form 13D |
| 4 | Lim Kok Thay Genting Berhad Resorts World Inc Pte. Ltd. 10% Owner | 2025-07-28 21:40:50 | 3,700,000 2,450,000 | 6,150,000 | Form 4 |
| 5 | Philip & Daniele Barach Family Trust 10% Owner | 2026-06-23 10:14:29 | 5,514,686 0 | 5,514,686 | Form 4 |
| 6 | Barach Philip Alan 10% Owner | 2026-06-23 10:13:54 | 0 5,514,686 | 5,514,686 | Form 4 |
| 7 | Barach Daniele Wolf 10% Owner | 2026-06-23 10:12:46 | 0 5,514,686 | 5,514,686 | Form 4 |
| 8 | Sorrento Therapeutics Inc. 10% Owner | 2023-10-05 17:22:14 | 5,050,427 0 | 5,050,427 | Form 13G |
| 9 | Hariri Robert J Chief Executive Officer | 2026-04-15 16:30:22 | 2,853,553 0 | 2,853,553 | Form 4 |
| 10 | Pecora Andrew L President | 2021-09-17 14:48:53 | 2,469,282 0 | 2,469,282 | Form 4 |
| 11 | Kilcoyne Adrian Chief Medical Officer | 2024-02-21 21:38:15 | 1,327,451 0 | 1,327,451 | Form 4 |
| 12 | SCULLEY JOHN Director | 2023-06-16 21:01:18 | 1,282,438 0 | 1,282,438 | Form 4 |
| 13 | Kehler Dean C Director | 2025-01-06 16:54:31 | 666,006 0 | 666,006 | Form 4 |
| 14 | VON ESCHENBACH ANDREW C. Director | 2023-06-16 21:02:25 | 613,844 0 | 613,844 | Form 4 |
| 15 | Parks Diane L. Director | 2026-01-15 16:15:32 | 520,021 0 | 520,021 | Form 4/A |
| 16 | Mazur Marc Director | 2023-06-16 21:02:41 | 513,844 0 | 513,844 | Form 4 |
| 17 | Smith Robin L Director | 2023-06-16 21:02:47 | 513,844 0 | 513,844 | Form 4 |
| 18 | Diamandis Peter Director | 2026-01-15 16:15:31 | 394,150 0 | 394,150 | Form 4/A |
| 19 | Glover Bradley See Remarks | 2023-04-17 21:12:44 | 351,192 0 | 351,192 | Form 4 |
| 20 | BERMAN RICHARD J Director | 2025-01-06 16:54:31 | 270,273 0 | 270,273 | Form 4 |
| 21 | Ling Geoffrey M.D. Director | 2026-01-15 16:15:29 | 256,026 0 | 256,026 | Form 4/A |
| 22 | LeVien Vincent Director | 2026-01-15 16:15:29 | 153,847 0 | 153,847 | Form 4/A |
| 23 | Mirakhur Beloo EVP, Clinical Development | 2021-09-15 18:50:54 | 125,000 0 | 125,000 | Form 4 |
| 24 | Dunn Keary See Remarks | 2022-04-28 21:04:29 | 64,505 0 | 64,505 | Form 4 |
| 25 | Bloom Jay R Director | 2021-09-13 18:03:21 | 56,053 0 | 56,053 | Form 4 |
| 26 | Jones Anne Chief Business Officer | 2022-11-18 20:16:41 | 49,154 0 | 49,154 | Form 4 |
| 27 | Haines John R Senior Exec Vice President | 2026-04-15 16:30:23 | 30,179 0 | 30,179 | Form 4 |
| 28 | DosSantos Joseph Interim CFO | 2025-07-16 08:24:27 | 30,000 0 | 30,000 | Form 3 |
| 29 | Fletcher Kyle See Remarks | 2024-04-16 20:56:13 | 21,085 0 | 21,085 | Form 4 |
| 30 | Beers David C Chief Financial Officer | 2025-04-15 16:30:24 | 19,226 0 | 19,226 | Form 4 |
| 31 | Brigido Stephen Pres., Functional Regeneration | 2026-04-15 16:30:25 | 9,474 0 | 9,474 | Form 4 |
| 32 | Kellett Andrea J. Chief Financial Officer | 2019-05-20 21:38:41 | 0 0 | 0 | Form 3 |
| 33 | Weinberger Hillel Director | 2019-05-20 21:40:12 | 0 0 | 0 | Form 3 |
| 34 | Maselli Michael G Vice President of Acquisitions | 2019-05-20 21:39:29 | 0 0 | 0 | Form 3 |
| 35 | LEVY PAUL S Director | 2019-05-20 21:39:04 | 0 0 | 0 | Form 3 |